Category: Medications - Page 3

29 Nov

Ankylosing Spondylitis: How TNF Inhibitors Reduce Spine Inflammation and Improve Mobility

TNF inhibitors have revolutionized treatment for ankylosing spondylitis, reducing spine inflammation and improving mobility for millions. Learn how these biologic drugs work, which ones are approved, who benefits most, and what to expect from treatment.

27 Nov

Generic Price Wars: How Consumers Save Money on Prescription Drugs

Generic drug price wars can slash prescription costs by over 95%, but middlemen often keep the savings. Learn how to access real savings on generics by comparing cash prices, using discount apps, and understanding market dynamics.

26 Nov

How to Read Pregnancy and Lactation Drug Labeling: A Clear Guide for Patients and Providers

Learn how to read the new FDA pregnancy and lactation drug labels that replaced outdated letter categories. Understand risk summaries, infant exposure, and clinical guidance for safer medication use during pregnancy and breastfeeding.

25 Nov

How to Prevent Compounding Errors for Customized Medications: A Practical Guide for Pharmacists

Preventing compounding errors in customized medications requires strict adherence to USP standards, dual verification, proper labeling, and staff training. Learn how to reduce risks and protect patients from potentially fatal mistakes.

24 Nov

How Formulation Patents on Drug Combinations Extend Pharmaceutical Exclusivity

Formulation patents on drug combinations let pharmaceutical companies extend market exclusivity by patenting specific dosages, delivery methods, or ingredient ratios - delaying generic competition and maintaining high prices for years after original patents expire.

23 Nov

Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market

Biosimilars in the U.S. can't enter the market until 12 years after a biologic's approval, thanks to patent protections and complex legal barriers. Learn how exclusivity rules, patent thickets, and high development costs delay competition-and what it means for patients.

20 Nov

Bioequivalence Testing for Generic Drugs: What It Proves

Bioequivalence testing proves generic drugs work the same as brand-name versions by measuring how your body absorbs them. It's the science behind safe, affordable medications.

20 Nov

How Healthcare Providers Can Advocate for Generic Medications to Improve Patient Outcomes

Healthcare providers play a key role in helping patients choose generic medications by explaining their safety, effectiveness, and cost benefits. Learn how clear communication improves adherence and reduces abandonment rates.

18 Nov

Compare Hydroxychloroquine (Hsquin) with Alternative Treatments

Hydroxychloroquine (Hsquin) is still used for lupus and rheumatoid arthritis, but its role has shrunk dramatically. This guide compares it with safer, more effective alternatives like methotrexate, artemisinin combos, and azithromycin - and explains when to avoid it.

18 Nov

Mefloquine in the News: Recent Developments and Research Breakthroughs

Mefloquine, once a top choice for malaria prevention, is now used only in rare cases due to serious side effects. Recent research shows declining drug resistance and new genetic screening options are reshaping how it's prescribed.